25695433|t|Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia.
25695433|a|Microglial cells are resident immune cells of the central nervous system (CNS), recognized as key elements in the regulation of neural homeostasis and the response to injury and repair. As excessive activation of microglia may lead to neurodegeneration, therapeutic strategies targeting its inhibition were shown to improve treatment of most neurodegenerative diseases. Benfotiamine is a synthetic vitamin B1 (thiamine) derivate exerting potentially anti-inflammatory effects. Despite the encouraging results regarding benfotiamine potential to alleviate diabetic microangiopathy, neuropathy and other oxidative stress-induced pathological conditions, its activities and cellular mechanisms during microglial activation have yet to be elucidated. In the present study, the anti-inflammatory effects of benfotiamine were investigated in lipopolysaccharide (LPS)-stimulated murine BV-2 microglia. We determined that benfotiamine remodels activated microglia to acquire the shape that is characteristic of non-stimulated BV-2 cells. In addition, benfotiamine significantly decreased production of pro-inflammatory mediators such as inducible form of nitric oxide synthase (iNOS) and NO; cyclooxygenase-2 (COX-2), heat-shock protein 70 (Hsp70), tumor necrosis factor alpha alpha (TNF-alpha), interleukin-6 (IL-6), whereas it increased anti-inflammatory interleukin-10 (IL-10) production in LPS stimulated BV-2 microglia. Moreover, benfotiamine suppressed the phosphorylation of extracellular signal-regulated kinases 1/2 (ERK1/2), c-Jun N-terminal kinases (JNK) and protein kinase B Akt/PKB. Treatment with specific inhibitors revealed that benfotiamine-mediated suppression of NO production was via JNK1/2 and Akt pathway, while the cytokine suppression includes ERK1/2, JNK1/2 and Akt pathways. Finally, the potentially protective effect is mediated by the suppression of translocation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) in the nucleus. Therefore, benfotiamine may have therapeutic potential for neurodegenerative diseases by inhibiting inflammatory mediators and enhancing anti-inflammatory factor production in activated microglia. 
25695433	0	12	Benfotiamine	Chemical	MESH:C013835
25695433	24	36	inflammatory	Disease	MESH:D007249
25695433	49	52	LPS	Chemical	MESH:D008070
25695433	64	68	BV-2	CellLine	CVCL:0182
25695433	315	332	neurodegeneration	Disease	MESH:D019636
25695433	422	448	neurodegenerative diseases	Disease	MESH:D019636
25695433	450	462	Benfotiamine	Chemical	MESH:C013835
25695433	478	488	vitamin B1	Chemical	MESH:D013831
25695433	490	498	thiamine	Chemical	MESH:D013831
25695433	535	547	inflammatory	Disease	MESH:D007249
25695433	599	611	benfotiamine	Chemical	MESH:C013835
25695433	635	659	diabetic microangiopathy	Disease	MESH:D003925
25695433	661	671	neuropathy	Disease	MESH:D009422
25695433	858	870	inflammatory	Disease	MESH:D007249
25695433	882	894	benfotiamine	Chemical	MESH:C013835
25695433	916	934	lipopolysaccharide	Chemical	MESH:D008070
25695433	936	939	LPS	Chemical	MESH:D008070
25695433	952	958	murine	Species	10090
25695433	959	963	BV-2	CellLine	CVCL:0182
25695433	994	1006	benfotiamine	Chemical	MESH:C013835
25695433	1098	1102	BV-2	CellLine	CVCL:0182
25695433	1123	1135	benfotiamine	Chemical	MESH:C013835
25695433	1178	1190	inflammatory	Disease	MESH:D007249
25695433	1250	1254	iNOS	Gene	18126
25695433	1264	1280	cyclooxygenase-2	Gene	19225
25695433	1282	1287	COX-2	Gene	19225
25695433	1290	1311	heat-shock protein 70	Gene	15511
25695433	1313	1318	Hsp70	Gene	15511
25695433	1356	1365	TNF-alpha	Gene	21926
25695433	1368	1381	interleukin-6	Gene	16193
25695433	1383	1387	IL-6	Gene	16193
25695433	1416	1428	inflammatory	Disease	MESH:D007249
25695433	1429	1443	interleukin-10	Gene	16153
25695433	1445	1450	IL-10	Gene	16153
25695433	1466	1469	LPS	Chemical	MESH:D008070
25695433	1481	1485	BV-2	CellLine	CVCL:0182
25695433	1507	1519	benfotiamine	Chemical	MESH:C013835
25695433	1554	1596	extracellular signal-regulated kinases 1/2	Gene	26417;26413
25695433	1598	1604	ERK1/2	Gene	26417;26413
25695433	1607	1631	c-Jun N-terminal kinases	Gene	26419
25695433	1633	1636	JNK	Gene	26419
25695433	1659	1662	Akt	Gene	11651
25695433	1663	1666	PKB	Gene	11651
25695433	1717	1729	benfotiamine	Chemical	MESH:C013835
25695433	1776	1782	JNK1/2	Gene	26419;26420
25695433	1787	1790	Akt	Gene	11651
25695433	1840	1846	ERK1/2	Gene	26417;26413
25695433	1848	1854	JNK1/2	Gene	26419;26420
25695433	1859	1862	Akt	Gene	11651
25695433	1967	2029	nuclear factor kappa-light-chain-enhancer of activated B cells	Gene	18033
25695433	2031	2040	NF-kappaB	Gene	18033
25695433	2069	2081	benfotiamine	Chemical	MESH:C013835
25695433	2117	2143	neurodegenerative diseases	Disease	MESH:D019636
25695433	2158	2170	inflammatory	Disease	MESH:D007249
25695433	2200	2212	inflammatory	Disease	MESH:D007249
25695433	Negative_Correlation	MESH:C013835	26419
25695433	Negative_Correlation	MESH:C013835	MESH:D003925
25695433	Negative_Correlation	MESH:C013835	MESH:D009422
25695433	Negative_Correlation	MESH:C013835	MESH:D019636
25695433	Association	MESH:D007249	16193
25695433	Association	MESH:C013835	26420
25695433	Negative_Correlation	MESH:C013835	19225
25695433	Positive_Correlation	MESH:C013835	16153
25695433	Negative_Correlation	MESH:C013835	MESH:D007249
25695433	Negative_Correlation	MESH:C013835	26417
25695433	Association	MESH:D007249	18126
25695433	Negative_Correlation	MESH:C013835	16193
25695433	Association	MESH:D007249	16153
25695433	Negative_Correlation	MESH:C013835	21926
25695433	Negative_Correlation	MESH:C013835	18126
25695433	Association	MESH:D007249	19225
25695433	Negative_Correlation	MESH:C013835	18033
25695433	Negative_Correlation	MESH:C013835	15511
25695433	Association	MESH:D007249	15511
25695433	Negative_Correlation	MESH:C013835	MESH:D008070
25695433	Negative_Correlation	MESH:C013835	26413
25695433	Negative_Correlation	MESH:C013835	11651

